IL6 and glioblastoma: Furthermore, it has been shown that BM-MSCs promote senescence of the U87 glioblastoma cell line by inducing changes in cell morphology and by increasing the production of cytokines (IL-6, IL-8, leukemia inhibitory factor (LIF), CCL2/MCP-1, and CXCL2) [119].